MENU
+Compare
BVNRY
Stock ticker: OTC
AS OF
Oct 15 closing price
Price
$12.60
Change
+$0.84 (+7.14%)
Capitalization
2.8B

BVNRY Bavarian Nordic A/S Forecast, Technical & Fundamental Analysis

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines... Show more

BVNRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BVNRY with price predictions
Oct 14, 2025

BVNRY in downward trend: 10-day moving average broke below 50-day moving average on September 29, 2025

The 10-day moving average for BVNRY crossed bearishly below the 50-day moving average on September 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BVNRY as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BVNRY moved below its 50-day moving average on September 25, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVNRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BVNRY entered a downward trend on October 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BVNRY advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

BVNRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BVNRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.474) is normal, around the industry mean (24.376). P/E Ratio (12.612) is within average values for comparable stocks, (54.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.175). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.789) is also within normal values, averaging (341.418).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVNRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BVNRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

BVNRY paid dividends on April 06, 2020

Bavarian Nordic A/S BVNRY Stock Dividends
А dividend of $0.59 per share was paid with a record date of April 06, 2020, and an ex-dividend date of March 27, 2020. Read more...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Philip Heymans Alle 3
Phone
+45 33268383
Employees
1379
Web
https://www.bavarian-nordic.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMFFX62.290.19
+0.31%
American Funds American Mutual R5
DPRDX13.510.04
+0.30%
Macquarie Global Listed Real Assets R6
GSESX69.01N/A
N/A
Goldman Sachs US Equity Insights Svc
QALGX38.90N/A
N/A
Federated Hermes MDT Large Cap Growth A
GSVRX15.94N/A
N/A
Goldman Sachs Large Cap Value R

BVNRY and Stocks

Correlation & Price change

A.I.dvisor tells us that BVNRY and GOVX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNRY and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNRY
1D Price
Change %
BVNRY100%
-0.89%
GOVX - BVNRY
28%
Poorly correlated
+8.83%
CRMD - BVNRY
24%
Poorly correlated
-0.28%
VRAX - BVNRY
23%
Poorly correlated
+1.54%
DMAC - BVNRY
22%
Poorly correlated
-3.12%
IPHA - BVNRY
21%
Poorly correlated
+2.53%
More